Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-25-000258
Filing Date
2025-02-19
Accepted
2025-02-19 16:02:47
Documents
68
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e6372_10q.htm   iXBRL 10-Q 822754
2 EXHIBIT 10.2 e6372_ex10-2.htm EX-10.2 99836
3 EXHIBIT 10.3 e6372_ex10-3.htm EX-10.3 129756
4 EXHIBIT 31.1 e6372_ex31-1.htm EX-31.1 8036
5 EXHIBIT 31.2 e6372_ex31-2.htm EX-31.2 8074
6 EXHIBIT 32.1 e6372_ex32-1.htm EX-32.1 4577
7 EXHIBIT 32.2 e6372_ex32-2.htm EX-32.2 4591
8 GRAPHIC ex10-3_logo.jpg GRAPHIC 4150
9 GRAPHIC image_002.gif GRAPHIC 1613
10 GRAPHIC image_003.gif GRAPHIC 2911
  Complete submission text file 0001731122-25-000258.txt   4840379

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE renb-20241231.xsd EX-101.SCH 39006
12 XBRL CALCULATION FILE renb-20241231_cal.xml EX-101.CAL 46802
13 XBRL DEFINITION FILE renb-20241231_def.xml EX-101.DEF 139600
14 XBRL LABEL FILE renb-20241231_lab.xml EX-101.LAB 318530
15 XBRL PRESENTATION FILE renb-20241231_pre.xml EX-101.PRE 266766
70 EXTRACTED XBRL INSTANCE DOCUMENT e6372_10q_htm.xml XML 537300
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO INC. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38758 | Film No.: 25639806
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)